Reduction of Cortical Bone Turnover and Erosion Depth After 2 and 3 Years of Denosumab: Iliac Bone Histomorphometry in the FREEDOM Trial
Author:
Affiliation:
1. INSERM UMR 1033; Université de Lyon; Lyon France
2. Amgen; Boulogne Billancourt; France
3. Department of Pathology and Cell Biology; Columbia University; New York NY USA
4. Amgen Inc; Thousand Oaks CA USA
Funder
Amgen
Publisher
Wiley
Subject
Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/jbmr.3631/fullpdf
Reference27 articles.
1. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand;Hsu;Proc Natl Acad Sci U S A,1999
2. Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo;Lacey;Am J Pathol,2000
3. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation;Lacey;Cell,1998
4. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women;Bone;J Clin Endocrinol Metab,2008
5. Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD;Lewiecki;J Bone Miner Res,2007
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Denosumab and the Rebound Effect: Current Aspects of Osteoporosis Therapy (Review);Safety and Risk of Pharmacotherapy;2024-06-06
2. A potential therapeutic drug for osteoporosis: prospect for osteogenic LncRNAs;Frontiers in Endocrinology;2023-08-03
3. Teriparatide Followed by Denosumab in Premenopausal Idiopathic Osteoporosis: Bone Microstructure and Strength by HR‐pQCT;Journal of Bone and Mineral Research;2022-11-24
4. Interest of Bone Histomorphometry in Bone Pathophysiology Investigation: Foundation, Present, and Future;Frontiers in Endocrinology;2022-07-28
5. Towards novel measurements of remodeling activity in cortical bone: implications for osteoporosis and related pharmaceutical treatments;European Cells and Materials;2022-05-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3